GlassScriptPhysician profile
Christopher P Vargo
NPI 1699095026
$1,203.18
in general payments reported to CMS, 2019-2025
10 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $175 · 2022: $153 · 2023: $379 · 2024: $262 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $874.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $256.93 | 2023-2025 | |
| Lilly USA, LLC | $192.18 | 2022-2025 | Kisunla, Amyvid |
| Boston Scientific Corporation | $130.59 | 2022 | |
| Abbvie INC. | $125.00 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $124.99 | 2023 | Rexulti |
| Axsome Therapeutics, INC. | $123.99 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $120.44 | 2021 | |
| Biogen, INC. | $54.74 | 2021 | |
| Scpharmaceuticals INC. | $51.39 | 2023 | |
| Corium, LLC | $22.93 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Vargo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.